APAC Contraceptive Market size is poised to surpass USD 12.9 billion by 2028, according to a latest forecast report by Graphical Research.

Advancements, innovations, and the integration of advanced technologies for promoting the consumer experience are anticipated to propel the contraceptives market revenue. Intrauterine technology has been constantly evolving with an increased range of applications in birth control. The smaller frameless copper and levonorgestrel-releasing devices are increasing the preference towards these devices among adolescent women. Companies are focusing to use new state-of-the-art technologies that enable them to develop strong and reliable contraceptive devices. These innovative solutions find application in preventing unwanted pregnancies and reducing the spread of sexually transmitted diseases (STDs). Similarly, the emergence of reusable, non-biodegradable, and flexible vaginal rings for up to 1 year of birth control delivers a safe, accurate, and reliable outcome. For instance, in August 2018, U.S. FDA approved the Annovera (segesterone acetate and ethinyl estradiol vaginal ring) to prevent unwanted pregnancy that can be used for an entire year.

Implementation of favourable initiatives by the government of several countries in the Asia Pacific region to upsurge knowledge regarding unwanted pregnancy and family planning is anticipated to produce huge product demand. Numerous programs aiming to cater to the unmet needs for modern contraception along with reproductive and sexual health services in developing economies of Asia Pacific are projected to surge participation of women, adolescents, and young population, at multiple stages of planning, implementation, and evaluation. The Indian government’s flagship initiative, National Programme for Family Planning, since its inception, has been continuously transforming in terms of policy and programme implementation to facilitate reproductive health in the country. These family planning services deliver contraceptive services at affordable costs, pregnancy testing & counseling, and wide-ranging reproductive health services among others.

The drugs segment will showcase around 9.6% CAGR between 2022 and 2028, attributed to the upsurge in concerns about family planning, increase in the use of contraceptives among young women, rise in awareness pertaining to modern contraception methods, etc. The demand for contraceptive drugs comprising topical contraceptives is set to surge with the increasing prevalence of sexually transmitted diseases in the Asia Pacific countries. For instance, as per the FPA India statistics, in 2018, the female populace aged 25 & below availed abortion services was 74,871; and 160,076 males aged 25 & below opted for general counseling for Family Planning and contraception. These statistics are expected to drive the adoption and use of contraceptives, thereby impelling the industry growth. Further, the surging R&D activities related to the development of contraceptive drugs have promoted the launch of innovative products in the market.

Browse detailed statistical insights from the report, “Asia Pacific Contraceptives Market Forecast 2028 By Product (Drugs {Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives}, Devices {Condoms [Male, Female], Diaphragms, Contraceptive Sponges, Vaginal Rings, Subdermal Implants, Intra-uterine Devices [Copper IUD, Hormonal IUD]}), Research Report, Country Outlook (China, Japan, India, Australia), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @
https://www.graphicalresearch.com/industry-insights/2140/asia-pacific-contraceptives-market

Japan contraceptive industry was valued at USD 518 million revenue in 2021, owing to the rise in the awareness pertaining to sexual & reproductive health, the increasing number of unwanted pregnancies, etc. The growing number of unwanted pregnancies in the country is providing considerable business growth avenues to the market players. According to the Health Ministry, in 2019, around 156,430 abortions were reported in Japan. Further, a significant incidence of sexually transmitted diseases in the country augments the market potential for contraceptives. Hence, government and non-government bodies in Japan are operating to prevent the prevalence of sexually transmitted diseases and unintended pregnancies in the country through the adoption of various contraceptive methods. For instance, Japan Family Planning Association is emphasizing to provide vital sexual and reproductive health services in the country.

APAC contraceptive market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2017 to 2028, for the following segments:

Asia Pacific Market, By Product

• Drugs
  • Oral Contraceptive Pills
  • Injectable Contraceptives
  • Topical Contraceptives  
• Devices
  • Condoms
    • Male
    • Female
  • Diaphragms
  • Contraceptive Sponges
  • Vaginal Rings
  • Subdermal Implants
  • Intra-uterine Devices
    • Copper IUD
    • Hormonal IUD

The above information has been provided for the following countries:

• Asia Pacific
  • China
  • Japan
  • India
  • Australia